Development and evaluation of portable compendium of psychophysical and physiological tests for alzheimer's disease and related dementias (adrd)

Ended Project Grant Awarded Last action

Award ID
R44AG082621
Recipient
Awarding agency
Obligated
$4,196,619

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Place of performance
Ilchester, MD 21043, USA

Award details come from USAspending.gov.

Description

Abstract
The development and evaluation of portable compendium of psychophysical and physiological tests for alzheimer's disease and related dementias (adrd) is a project to develop an inexpensive, user-friendly, digital chemosensory-sensorimotor acquisition and processing device, with cross-cultural validity for home or office use for automated (a) staging of severity of age-related cognitive decline, (b) prognostication of people with subjective cognitive impairment at risk for progressive neurodegenerative diseases, and (c) remote surveillance of trajectory in motor and chemosensory markers of adrd progression in elderly populations. Given that some decline in cognition is expected with advancing age, IT is very challenging for elderly people to determine if their cognitive challenges are normal for age, or pathological. Similarly, our stakeholder survey of physicians who treat geriatric populations revealed that

Transactions

Action Obligated Date
Amendment $1,249,244
Amendment $1,249,244
Amendment $1,249,244
Original award $448,887

Quick answers

Who received award R44AG082621?

R44AG082621 was awarded to Evon Medics LLC by National Institute on Aging (National Institutes of Health) on August 1, 2023.

How much is award R44AG082621 worth?

$4,196,619 has been obligated on R44AG082621.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award